Export 8 results:
Search results for biblio_year:2016
Filters: Author is Morotti, Stefano  [Reset Search]
2022
X. Zhang, H. Ni, S. Morotti, C. E. R. Smith, D. Sato, W. E. Louch, A. G. Edwards and E. Grandi. "Mechanisms of spontaneous Ca 2+ release‐mediated arrhythmia in a novel 3D human atrial myocyte model: I. Transverse‐axial tubule variation." The Journal of Physiology (2022).
X. Zhang, C. E. R. Smith, S. Morotti, A. G. Edwards, D. Sato, W. E. Louch, H. Ni and E. Grandi. "Mechanisms of spontaneous Ca2+ release‐mediated arrhythmia in a novel 3D human atrial myocyte model: II Ca2+‐handling protein variation." The Journal of Physiology 116 (2022).
2021
A. F. Iseppe, H. Ni, S. Zhu, X. Zhang, R. Coppini, P. Yang, U. Srivatsa, C. E. Clancy, A. G. Edwards, S. Morotti et al. "Sex‐Specific Classification of Drug‐Induced Torsade de Pointes Susceptibility Using Cardiac Simulations and Machine Learning." Clinical Pharmacology & Therapeutics 1105970708108167, no. 2 (2021): 380-391.
2018
S. Morotti, N. Ellinwood, H. Ni, J. T. Koivumäki, M. Maleckar, J. Heijman, D. Dobrev and E. Grandi. "Effects of modulation of small-conductance calcium-activated potassium current on atrial electrophysiology and arrhythmogenesis: a population-based computational study." Biophysical Journal 114 (2018): 473a.
2016
S. Morotti, A. D. McCulloch, D. M. Bers, A. G. Edwards and E. Grandi. "Atrial-selective targeting of arrhythmogenic phase-3 early afterdepolarizations in human myocytes." Journal of Molecular and Cellular Cardiology 96 (2016): 63-71.
S. Morotti, J. T. Koivumäki, M. Maleckar, N. Chiamvimonvat and E. Grandi. "Small-conductance Ca2+-activated K+ current in atrial fibrillation: both friend and foe." Biophysical Journal 110 (2016): 274a.
2015
S. Morotti, A. D. McCulloch, D. M. Bers, A. G. Edwards and E. Grandi. "Atrial-selective targeting of arrhythmogenic phase-3 early afterdepolarizations in human myocytes." Journal of Molecular and Cellular Cardiology In Press (2015).
S. Morotti, A. D. McCulloch, D. M. Bers, A. G. Edwards and E. Grandi. Ranolazine Prevents Phase-3 Early Afterdepolarizations in Human Atrial Myocytes by Inhibiting Na Current Non-Equilibrium Reactivation In Biophysical Society annual meeting. Elsevier, 2015.